Peak Bio, Inc. (PKBOW)
USD 0.01
(4850.01%)
USD 0.01
(4850.01%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 367.87 Thousand | 607.68 Thousand | 528.3 Thousand | - | - |
| Cost of Revenue | 107.10 | 108.58 | - | - | - |
| Gross Profit | 367.76 Thousand | 607.57 Thousand | 528.3 Thousand | - | - |
| Operating Expenses | 1249.13 | 12.45 Million | 9.59 Million | 2607.59 | 1269.45 |
| Selling, General and Administrative Expenses | 1249.13 | 8.53 Million | 2.46 Million | 2350.32 | 1230.48 |
| Research and Development Expenses | - | 3.92 Million | 7.12 Million | - | - |
| Other Expenses | - | -819.06 Thousand | - | - | - |
| Cost and Expenses | 1356.23 | 12.45 Million | 9.59 Million | 2607.59 | 1269.45 |
| Operating Income | -1356.23 | -11.84 Million | -9.06 Million | -2389.59 | -1238.85 |
| Interest Expense | - | 47.95 Thousand | 11.47 Thousand | - | - |
| Income Tax Expense | - | -74 Thousand | 82.06 Thousand | - | - |
| Earnings before Tax | -1259.26 | -13.16 Million | -8.21 Million | -2458.29 | -1267.88 |
| Net Income | -1259.26 | -13.08 Million | -8.29 Million | -2458.29 | -1267.88 |
| Earnings Per Share Basic | - | -0.74 | -0.48 | -0.00 | -0.00 |
| Earnings Per Share Diluted | - | -0.74 | -0.48 | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 29.54 Million | 17.71 Million | 17.16 Million | 6.71 Million | 3.64 Million |
| Weighted Average Shares Outstanding (Diluted) | 29.54 Million | 17.71 Million | 17.16 Million | 6.71 Million | 3.64 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | - | - |
| EBIT Margin | -0.00 | -19.55 | -16.82 | - | - |
| Profit Margin | -0.00 | -21.54 | -15.70 | - | - |
| EBITDA | -1356.23 | -12.32 Million | -8.02 Million | -2350.32 | -1230.48 |
| Earnings Before Tax Margin | -0.00 | -19.50 | -17.16 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 367.87 Thousand | 75.19 Thousand | 278.83 Thousand | - |
| Cost of Revenue | - | - | 107.10 | 16.66 | 32.62 | 15.17 |
| Gross Profit | - | - | 367.76 Thousand | 75.17 Thousand | 278.79 Thousand | -15.17 |
| Operating Expenses | 1.39 Million | 2.2 Million | 1354.96 | 1.14 Million | 2.03 Million | 2.67 Million |
| Selling, General and Administrative Expenses | 1.28 Million | 2.13 Million | - | 1.23 Million | 1.75 Million | 2.29 Million |
| Research and Development Expenses | 108.64 Thousand | 70.26 Thousand | - | -9858.00 | 552.98 Thousand | 371.15 Thousand |
| Other Expenses | 11.00 | 207.97 Thousand | - | 232.00 | 46.12 Thousand | -29.00 |
| Cost and Expenses | 1.39 Million | 2.2 Million | 1462.06 | 1.14 Million | 2.03 Million | 2.67 Million |
| Operating Income | -1.39 Million | -2.2 Million | -1410.95 | -1.14 Million | -2.03 Million | -2.67 Million |
| Interest Expense | 448.96 Thousand | 323.14 Thousand | -2.72 Million | 448.16 Thousand | 1.21 Million | 998.54 Thousand |
| Income Tax Expense | 448.97 Thousand | 531.11 Thousand | - | 448.4 Thousand | 1.26 Million | 998.51 Thousand |
| Earnings before Tax | -2.07 Million | -2.43 Million | -1259.26 | -525.44 Thousand | 410.58 Thousand | -5.94 Million |
| Net Income | -2.07 Million | -2.43 Million | -1259.26 | -525.44 Thousand | 410.58 Thousand | -5.94 Million |
| Earnings Per Share Basic | -0.09 | -0.11 | - | -0.02 | 0.01 | -0.29 |
| Earnings Per Share Diluted | -0.09 | -0.11 | - | -0.02 | 0.01 | -0.29 |
| Weighted Average Shares Outstanding | 23.12 Million | 23.12 Million | 29.54 Million | 23.12 Million | 35.96 Million | 20.25 Million |
| Weighted Average Shares Outstanding (Diluted) | 23.12 Million | 23.12 Million | 29.54 Million | 23.12 Million | 35.96 Million | 20.25 Million |
| Gross Margin | - | - | 1.00 | 1.00 | 1.00 | - |
| EBIT Margin | - | - | - | -14.81 | -6.99 | - |
| Profit Margin | - | - | -0.00 | -6.99 | 1.47 | - |
| EBITDA | -1.36 Million | -1.96 Million | - | -1.11 Million | -1.95 Million | -2.63 Million |
| Earnings Before Tax Margin | - | - | -0.00 | -15.25 | -7.28 | - |
HAUTO
AQMS
HOM-UN
BONDADA
DSNG
603949